Article

Lamellar sliver: devastating complication of recutting after LASIK

Lamellar sliver: devastating complication of recutting after LASIK

A lamellar sliver is a devastating complication resulting from recutting flaps during LASIK enhancement procedures, saidJonathan Song, MD, from the Doheny Eye Institute, Los Angeles.

Re-treatment, he noted, is needed in 3% to 10% of patients who under go LASIK. Initially, after LASIK was introducedrecutting was advised after 6 months; later relifting was advised after 1 year and then after 2 years. However, a seriouscomplication, lamellar sliver, which is tissue missing from the flap as a result of recutting, was reported to have causedirregular astigmatism and decreased visual acuity. Twelve patients were found to have this complication after proceduresperformed by nine experienced surgeons; all patients had irregular astigmatism, significant loss of best-corrected visualacuity, and very high subjective visual difficulties.

To prevent the lamellar sliver, Dr. Song advised surgeons to relift all flaps if possible-relifting can be done up to 10years using a needle or a depression technique.

"The technique that I prefer in patients with a relatively new flap the edge of the edge of the flap can be depressed and ablunt instrument used to go inside the edge," he said. "A spatula can be used to loosen any adhesion."

After re-treatment, the edges should be clean and any loose epithelium removed. A bandage contact lens can be considered. Ifthe flap is difficult to lift, he suggested converting to surface ablation with mitomycin C.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.